George Michael Loses Fight against Chronic lymphocytic leukemia

George Michael, the star of the George Michael Sports Machine, has died of cancer. Chronic lymphocytic leukemia is one of four main types of leukemia, which affects over 85,000 people in the United States.
George Michael, a high-rated and hyperanimated Washington sportscaster, was 70 years old when he passed away. Michael's highlight-rich program, which launched in 1984, eventually morphed into "The George Michael Sports Machine." It grew into the first nationally syndicated sports highlights show, eventually airing in 194 markets across the United States and in 10 foreign countries.
"George was the consummate reporter and a valuable friend," Washington Redskins owner Daniel Snyder said in a statement. "I doubt we'll ever again see a sports reporter who was so admired by the people he covered."
“He waged his battle against cancer with the same drive and determination that made him a one-of-a-kind in the broadcasting industry,” the family said in a statement. “Whether it was covering a sports story, working on his horse farm, or spending time with family and friends, he approached everything in life with passion.”

The exact underlying cause of chronic lymphocytic leukemia is unknown, but it begins with mutation in the DNA of a single cell. Symptoms include low energy levels, shortness of breath, weight loss, swollen lymph nodes, and an increased number of infections.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap